# The Effect of Rosuvastatin and Olmesartan on the Progression of Coronary Atherosclerotic Disease

> **NCT02516826** · PHASE2 · UNKNOWN · sponsor: **Samsung Medical Center** · enrollment: 504 (estimated)

## Conditions studied

- Coronary Syndrome

## Interventions

- **DRUG:** Rosuvastatin
- **DRUG:** Olmesartan
- **DRUG:** Combination
- **DRUG:** Placebo of Rosuvastatin
- **DRUG:** Placebo of Olmesartan
- **DRUG:** Placebo of Rosuvastatin/Olmesartan(Combination)

## Key facts

- **NCT ID:** NCT02516826
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-08
- **Primary completion:** 2018-08
- **Final completion:** 2018-08
- **Target enrollment:** 504 (ESTIMATED)
- **Last updated:** 2015-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02516826

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02516826, "The Effect of Rosuvastatin and Olmesartan on the Progression of Coronary Atherosclerotic Disease". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02516826. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*